Sex hormonal status affects meal stimulated plasma 5-hydroxytryptamine (5-HT) levels in female patients with diarrhoea predominant irritable bowel syndrome (d-IBS)

被引：0
|
作者：
Atkinson, W
Houghton, LA
Whorwell, PJ
Whitaker, P
机构：
[1] Univ S Manchester Hosp, Dept Med, Manchester M20 8LR, Lancs, England
[2] Leicester Royal Infirm, Leicester, Leics, England
来源：
GUT | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
142
引用
收藏
页码：A38 / A39
页数：2
相关论文
共 38 条
  • [31] Evidence for increased plasma 5-hydroxytryptamine (5-HT) concentration following meal ingestion in patients with functional dyspepsia (FD) and its relationship to gender and symptoms
    Lea, R
    Houghton, LA
    Whorwell, P
    Whitaker, P
    GASTROENTEROLOGY, 2002, 122 (04) : A35 - A35
  • [32] EFFECTS OF VITAMIN D3 SUPPLEMENTATION ON CLINICAL SYMPTOMS, QUALITY OF LIFE, SERUM SEROTONIN (5-HYDROXYTRYPTAMINE), 5-HYDROXY-INDOLE ACETIC ACID, AND RATIO OF 5-HIAA/5-HT IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A RANDOMIZED CLINICAL TRIAL
    Sikaroudi, Masoumeh Khalighi
    Mokhtare, Marjan
    Shidfar, Farzad
    Janani, Leila
    Kashani, AmirHossein Faghihi
    Masoodi, Mohsen
    Agah, Shahram
    Dehnad, Afsaneh
    Shidfar, Shahrzad
    EXCLI JOURNAL, 2020, 19 : 652 - 667
  • [33] 5-HT3 Receptor Partial Agonist Modulation, a Novel Approach to the Treatment of Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
    Manning, David
    Wierschke, Jonathan D.
    Barnes, Nicholas M.
    Moore, Nicholas
    GASTROENTEROLOGY, 2011, 140 (05) : S616 - S616
  • [34] Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients
    Sen, Fatma
    Pinarbasi, Binnur
    Issever, Halim
    Akyuz, Filiz
    Mungan, Zeynel
    Kaymakoglu, Sabahattin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (03): : 270 - 278
  • [35] Correlation between serum neuropeptide Y, substance P, and 5-HT expression and anxiety and depression in constipation-predominant irritable bowel syndrome patients
    Guo, Lianrong
    Zhao, Yanying
    Liu, Bin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8331 - 8337
  • [36] The Effect of Proton Pump Inhibitor (PPI) on Plasma 5-Hydroxytryptamine (5-HT) Levels in Patients With Functional Dyspepsia (FD): A Double-Blind Randomized Control Trial
    Cheung, Cynthia K.
    Lee, Yingying
    Chan, Yawen
    Chan, Angie
    Law, Wai Tak W.
    Lan, Lin Lin
    Lee, Vivian W.
    Wu, Justin C.
    GASTROENTEROLOGY, 2013, 144 (05) : S679 - S679
  • [37] A randomized, double-blind, placebo-controlled trial with a novel dual noradrenergic reuptake inhibitor (NARI) and 5-HT3 antagonist: Results of a phase II 8-week study in female patients with diarrhea predominant irritable bowel syndrome (D-IBS)
    Paterson, William G.
    Sponger, Jonathon
    O'Mahony, Michael
    Reynolds, Richard P.
    Ganguli, Subhas C.
    Feagan, Brian
    Nurbhai, Suhail
    Landau, Steven B.
    GASTROENTEROLOGY, 2008, 134 (04) : A50 - A50
  • [38] Tickling the 5-HT3 receptor: Potential therapeutic opportunities for patients with diarrhea-predominant Irritable Bowel Syndrome (IBS) from the selective 5-HT3 receptor partial agonist, CSTI-300
    Roberts, A.
    Grafton, G.
    Mo, Y.
    Meng, D.
    Xie, D.
    Liu, S.
    Guzzo, P.
    Barnes, N.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 : 81 - 81
1234